Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling

Oncogene

Volumn 33, Issue 5, 2014, Pages 665-670

  Zeilstra, J ^a   Joosten, S P J ^a   Van Andel, H ^a   Tolg, C ^b   Berns, A ^b   Snoek, M ^b   Van De Wetering, M ^c   Spaargaren, M ^a   Clevers, H ^c   Pals, S T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; HYALURONIC ACID; LIGAND; MESSENGER RNA; MESSENGER RNA PRECURSOR; SCATTER FACTOR; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CELL MIGRATION; CELL RENEWAL; CELL TRANSFORMATION; CELL TYPE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL COLON POLYPOSIS; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INTESTINE CANCER; INTESTINE EPITHELIUM CELL; METASTASIS INHIBITION; MICROADENOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; ANTIGENS, CD44; CELL TRANSFORMATION, NEOPLASTIC; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE KNOCK-IN TECHNIQUES; INTESTINAL NEOPLASMS; MICE; MICE, TRANSGENIC; NEOPLASTIC STEM CELLS; PROTEIN ISOFORMS; RECEPTORS, G-PROTEIN-COUPLED; TUMOR CELLS, CULTURED; WNT SIGNALING PATHWAY;

EID: 84893328640     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.611     Document Type: Article

References (39)

1. Noah TK, Donahue B, Shroyer NF. Intestinal development and differentiation. Exp Cell Res 2011; 317: 2702-2710.
2. Kuhnert F, Davis CR, Wang HT, Chu P, Lee M, Yuan J et al. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc Natl Acad Sci USA 2004; 101: 266-271.
3. Nusse R. Wnt signaling and stem cell control. Cell Res 2008; 18: 523-527.
4. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-170.
5. Korinek V, Barker N, Morin PJ, Van Wichen D, De Weger R, Kinzler KW et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 1997; 275: 1784-1787.
6. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787-1790.
7. Barker N, Ridgway RA, Van Es JH, Van De Wetering M, Begthel H, Van Den Born M et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009; 457: 608-611.
8. Van De Wetering M, Sancho E, Verweij C, De Lau W, Oving I, Hurlstone A et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002; 111: 241-250.
9. Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 2004; 18: 1385-1390.
10. Van Der Flier LG, Sabates-Bellver J, Oving I, Haegebarth A, De Palo M, Anti M et al. The intestinal Wnt/TCF signature. Gastroenterology 2007; 132: 628-632.
11. Van Der Flier LG, Van Gijn ME, Hatzis P, Kujala P, Haegebarth A, Stange De et al. Transcription factor achaete scute-like controls intestinal stem cell fate. Cell 2009 136 903-912.
12. Merlos-Suarez A, Barriga FM, Jung P, Iglesias M, Cespedes MV, Rossell D et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011; 8: 511-524
13. Heider KH, Hofmann M, Hors E, Van Den Berg F, Ponta H, Herrlich P et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120: 227-233.
14. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, Van Den Berg FM, Ponta H et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993; 53: 4754-4756.
15. Mulder JW, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994; 344: 1470-1472.
16. Zoller M. CD44: Can a cancer-initiating cell profit from an abundantly expressed molecule Nat Rev Cancer 2011; 11: 254-267.
17. Bennett KL, Modrell B, Greenfield B, Bartolazzi A, Stamenkovic I, Peach R et al. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol 1995; 131: 1623-1633.
18. Van Der Voort R, Taher TE, Wielenga VJ, Spaargaren M, Prevo R, Smit L et al. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem 1999; 274: 6499-6506.
19. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 1995; 128: 673-685.
20. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999; 154: 515-523.
21. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158-10163.
22. Zeilstra J, Joosten SP, Dokter M, Verwiel E, Spaargaren M, Pals ST. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/) mice attenuates intestinal tumorigenesis. Cancer Res 2008; 68: 3655-3661.
23. Wielenga VJ, Van Der Neut R, Offerhaus GJ, Pals ST. CD44 glycoproteins in colorectal cancer: Expression, function, and prognostic value. Adv Cancer Res 2000; 77: 169-187.
24. Barker N, Van Es JH, Kuipers J, Kujala P, Van Den Born M, Cozijnsen M et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-1007.
25. Van Weering DH, Baas PD, Bos JL. A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl 1993; 3: 100-106.
26. Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R et al. Pathology of mouse models of intestinal cancer: Consensus report and recommendations. Gastroenterology 2003; 124: 762-777.
27. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 2002; 16: 3074-3086.
28. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915-925.
29. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L et al. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1995; 1: 147-154.
30. Wielenga VJ, Van Der Voort R, Taher TE, Smit L, Beuling EA, Van Krimpen C et al. Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. Am J Pathol 2000; 157: 1563-1573.
31. Boon EM, Van Der Neut R, Van De Wetering M, Clevers H, Pals ST. Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer. Cancer Res 2002; 62: 5126-5128.
32. Vermeulen L, De Sousa EMF, Van Der Heijden M, Cameron K, De Jong JH, Borovski T et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010; 12: 468-476.
33. Van Der Voort R, Manten-Horst E, Smit L, Ostermann E, Van Den Berg F, Pals ST. Binding of cell-su-rface expressed CD44 to hyaluronate is dependent on splicing and cell type. Biochem Biophys Res Commun 1995; 214: 137-144.
34. Toole BP. Hyaluronan: From extracellular glue to pericellular cue. Nat Rev Cancer 2004; 4: 528-539.
35. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-444.
36. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 2003; 339: 62-66.
37. 37 Van Der Neut R, Krimpenfort P, Calafat J, Niessen CM, Sonnenberg A. Epithelial detachment due to absence of hemidesmosomes in integrin beta null mice. Nat Genet 1996; 13: 366-369.
38. Schmits R, Filmus J, Gerwin N, Senaldi G, Kiefer F, Kundig T et al. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997; 90: 2217-2233.
39. McCart AE, Vickaryous NK, Silver A. Apc mice: Models, modifiers and mutants. Pathol Res Pract 2008; 204: 479-490.